These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1628 related articles for article (PubMed ID: 8457627)

  • 1. A tumor-elaborated supernatant factor chemotactic for IL-2 expanded tumor infiltrating T-lymphocytes.
    Averbook BJ; Wei JP; Perry-Lalley DM; Rosenberg SA; Yang JC
    Lymphokine Cytokine Res; 1993 Feb; 12(1):1-8. PubMed ID: 8457627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.
    Nagoshi M; Goedegebuure PS; Burger UL; Sadanaga N; Chang MP; Eberlein TJ
    J Immunol; 1998 Jan; 160(1):334-44. PubMed ID: 9551989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice.
    Mrowietz U; Schwenk U; Maune S; Bartels J; Küpper M; Fichtner I; Schröder JM; Schadendorf D
    Br J Cancer; 1999 Mar; 79(7-8):1025-31. PubMed ID: 10098731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 activated microglia engulf tumor infiltrating T cells in the central nervous system.
    Tamakawa N; Saio M; Suwa T; Ohe N; Yoshimura S; Iwama T; Shinoda J; Sakai N; Takami T
    Int J Mol Med; 2004 Apr; 13(4):497-503. PubMed ID: 15010848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of mononuclear cells infiltrating into tumors. III. Soluble factors involved in the regulation of T lymphocyte infiltration into tumors.
    Yamaki T; Uede T; Shijubo N; Kikuchi K
    J Immunol; 1988 Jun; 140(12):4388-96. PubMed ID: 3286773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor infiltrating lymphocytes: CD8+ lymphocytes in canine transmissible venereal sarcomas at different stages of tumor growth.
    Barber MR; Yang TJ
    Anticancer Res; 1999; 19(2A):1137-42. PubMed ID: 10368665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
    J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of adoptive immunotherapy: improved methods for in vivo tracking of tumor-infiltrating lymphocytes and lymphokine-activated killer cells.
    Wallace PK; Palmer LD; Perry-Lalley D; Bolton ES; Alexander RB; Horan PK; Yang JC; Muirhead KA
    Cancer Res; 1993 May; 53(10 Suppl):2358-67. PubMed ID: 8485722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients.
    Besser MJ; Shapira-Frommer R; Treves AJ; Zippel D; Itzhaki O; Schallmach E; Kubi A; Shalmon B; Hardan I; Catane R; Segal E; Markel G; Apter S; Nun AB; Kuchuk I; Shimoni A; Nagler A; Schachter J
    J Immunother; 2009 May; 32(4):415-23. PubMed ID: 19342963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 co-stimulation.
    Seeley BM; Barthel SW; To WC; Kjaergaard J; Shu S; Plautz GE
    Otolaryngol Head Neck Surg; 2001 Apr; 124(4):436-41. PubMed ID: 11283503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant reduction of T-cell chemotaxis to MCP-1 in patients with primary and metastatic melanoma.
    Zheng M; Sun G; Cai S; Mueller R; Mrowietz U
    Chin Med J (Engl); 1999 Jun; 112(6):493-6. PubMed ID: 11601324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells.
    Inoue M; Plautz GE; Shu S
    Cancer Res; 1996 Oct; 56(20):4702-8. PubMed ID: 8840987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma.
    Lockhart DC; Chan AK; Mak S; Joo HG; Daust HA; Carritte A; Douville CC; Goedegebuure PS; Eberlein TJ
    Surgery; 2001 Jun; 129(6):749-56. PubMed ID: 11391375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors.
    Søndergaard H; Frederiksen KS; Thygesen P; Galsgaard ED; Skak K; Kristjansen PE; Odum N; Kragh M
    Cancer Immunol Immunother; 2007 Sep; 56(9):1417-28. PubMed ID: 17285290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive activity of cloned natural killer (NK1.1+) T cells established from murine tumor-infiltrating lymphocytes.
    Tamada K; Harada M; Abe K; Li T; Tada H; Onoe Y; Nomoto K
    J Immunol; 1997 May; 158(10):4846-54. PubMed ID: 9144500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7.1 immunogene therapy effectively activates CD(4+) tumor-infiltrating lymphocytes in the central nervous system in comparison with B7.2 gene therapy.
    Ando H; Saio M; Ohe N; Tamakawa N; Yu H; Nakayama T; Yoshimura S; Kaku Y; Iwama T; Shinoda J; Sakai N; Takami T
    Int J Oncol; 2002 Apr; 20(4):807-12. PubMed ID: 11894129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene.
    Cao X; Wang Q; Ju DW; Tao Q; Wang J
    J Exp Clin Cancer Res; 1999 Jun; 18(2):191-200. PubMed ID: 10464706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.
    Asselin-Paturel C; Megherat S; Vergnon I; Echchakir H; Dorothée G; Blesson S; Gay F; Mami-Chouaib F; Chouaib S
    Cancer; 2001 Jan; 91(1):113-22. PubMed ID: 11148567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.